Novo Nordisk A/S (NVO) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Novo Nordisk A/S (NVO) over the last 10 years. The current PE ratio for Novo Nordisk A/S as of August 23, 2017 is 20.51.
|Medical||Large Cap Pharmaceutical||$117.683B||$15.976B|
|Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.|